Abdirasulova ZA, Jabbar BH, Ismael SH, Hussein AM, Saleh S, Nazir NK. The Usage and Limitations of Gene Therapy Versus Stem Cell Therapy for Myotonic Dystrophy Type 1 (DM1): Special Focus on Immune Response. Trends Immunother. [Internet]. 2026 Jan. 6 [cited 2026 Mar. 7];10(1):189-203. Available from: https://ojs.ukscip.com/index.php/ti/article/view/1105